Molecular Weight: 4813.527 Da | 39 Amino Acids | Form: Lyophilized | Purity: 99%+ HPLC
GLP2-T (Tirzepatide) is a 39-amino-acid GIP-backbone dual agonist that simultaneously activates both GLP-1 and GIP receptors — making it structurally distinct from single-receptor GLP-1 analogues. It is studied for dual-pathway appetite signaling, glucose-dependent insulin secretion, adiponectin pathway research, and metabolic regulation. Each vial contains 50mg of lyophilized GLP2-T at 99%+ HPLC-verified purity, with a batch-specific Certificate of Analysis available for download. *
GLP2-T
Tirzepatide (GLP-1 + GIP dual agonist)
Mechanism of Action• Dual Receptor Activation (GLP-1R + GIPR): Simultaneously activates both GLP-1 and GIP receptors, providing a two-pathway metabolic signal studied for additive/synergistic effects in preclinical models.
• Glucose-Dependent Insulin Secretion: Researched for stimulating insulin release via both GLP-1 and GIP receptor pathways, contributing to glucose-regulation research.
• Adiponectin & Insulin Sensitivity: Researched for increasing adiponectin levels and improving insulin sensitivity in metabolic pathway models.
Together these make GLP2-T a key tool in dual-receptor, appetite-signaling, insulin-regulation, and adiponectin-pathway research.
| Compound | GLP2-T (Tirzepatide — GLP-1 + GIP dual agonist) |
| Sequence | YE-Aib-GTFTSDYSI-Aib-LDKIAQAFVQWLIAGGPSSGAPPPS |
| Amino Acids | 39 |
| Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| MW | 4813.527 g/mol |
| CAS Number | 2023788-19-2 |
| Synonym | Tirzepatide · LY3298176 · P1206 |
| Purity | ≥ 99% HPLC |
| Identity | LC-MS Verified |
| Form | Lyophilized powder |
| Vial Size | 3mL glass vial ·50mg |
| Additives | None |
| Batch COA | Available for download |
- Dual GLP-1 + GIP receptor binding & incretin-pathway research
- Dual-pathway appetite signaling & satiety research
- Glucose-dependent insulin secretion & metabolic balance research
- Adiponectin pathway & insulin-sensitivity research models
- Non-alcoholic fatty liver & metabolic-syndrome preclinical models
- Comparison studies vs single GLP-1 or GIP agonists
Storage: Store lyophilized powder at -20°C long term; once reconstituted, store at 4°C, protect from light and moisture.
Handling: Research use only; handle by licensed, qualified professionals with PPE. Reconstitution chemistry is the sole responsibility of the receiving research institution.
FEATURED INGREDIENTS
All Ingredients
Dual Receptor Agonist
Activates both GLP-1 and GIP receptors at once — the key feature that sets it apart from single-receptor GLP-1 analogues in metabolic research.
Two-Pathway Satiety Research
Studied for sending "fullness" signals through two separate receptor pathways — GLP-1 and GIP — in appetite and metabolic research models.
Insulin & Adiponectin Research
Researched for stimulating insulin release and increasing adiponectin — a hormone linked to metabolic health — via dual-receptor activation.
PRODUCT BENEFITS
-
Dual Receptor Agonist (GLP-1 + GIP) GIP-backbone peptide that activates both GLP-1 and GIP receptors simultaneously — the defining feature that sets GLP2-T apart from single-receptor GLP-1 analogues.
-
Appetite Control Research Studied for helping the body feel full by sending "stop eating" signals from the gut to the brain — relevant to appetite and energy-intake research.
-
Blood Sugar Research Researched for signaling the pancreas to release insulin when blood sugar is high — studied in glucose-regulation and beta-cell research models.
-
Stomach Emptying Research Studied for slowing how fast food leaves the stomach, helping control how quickly nutrients enter the blood in metabolic models.
-
Heart & Brain Research Examined in cardiac-function and neuroprotection models, including amyloid-beta research relevant to neurological pathway studies.
-
99%+ HPLC-Verified Purity Independently verified by third-party labs via HPLC and LC-MS; batch-specific COA and SDS available pre-purchase.
CUSTOMERS ALSO PURCHASED
Loved by thousands
Bundle and save 20%
GLP2-T activates two metabolic receptors at the same time — GLP-1 and GIP — making it the only dual-agonist in this class. GLP-1 receptor activation sends "fullness" signals and triggers insulin release. GIP receptor activation adds a second insulin signal and researched for increasing adiponectin and improving insulin sensitivity. Together they are studied for a synergistic metabolic effect not seen in single-receptor compounds.*

WHAT TO EXPECT
Independently verified by third-party labs
Batch number printed on every vial
Orders before 2 PM EST ship same business day
Plain FedEx/UPS, return label: Shipping Manager
Real human responses within hours
Independently verified by third-party labs
Batch number printed on every vial
Orders before 2 PM EST ship same business day
Plain FedEx/UPS, return label: Shipping Manager
Real human responses within hours
GIP + GLP-1 Dual Receptor Activation
Simultaneously binds and activates both the GIP receptor (GIPR) and GLP-1 receptor (GLP-1R) — providing a two-channel metabolic signal that is studied for additive and synergistic effects compared to single-receptor agonists.
Appetite Signaling & Insulin Secretion
Studied for sending gut-to-brain fullness signals through both receptor pathways and for stimulating glucose-dependent insulin release — contributing to metabolic balance research.
Adiponectin Pathway & Insulin Sensitivity
Researched for increasing adiponectin levels and improving the body's response to insulin in metabolic pathway models — effects attributed to GIP receptor activation that GLP-1-only compounds do not provide.
ALL DETAILS
- GIP + GLP-1 Dual Receptor Activation — Simultaneously binds and activates both the GIP receptor (GIPR) and GLP-1 receptor (GLP-1R) — providing a two-channel metabolic signal that is studied for additive and synergistic effects compared to single-receptor agonists.
- Appetite Signaling & Insulin Secretion — Studied for sending gut-to-brain fullness signals through both receptor pathways and for stimulating glucose-dependent insulin release — contributing to metabolic balance research.
- Adiponectin Pathway & Insulin Sensitivity — Researched for increasing adiponectin levels and improving the body's response to insulin in metabolic pathway models — effects attributed to GIP receptor activation that GLP-1-only compounds do not provide.
The "GLP1-T" Peptide |
No fillers | No artificial additives | No excipients | 99%+ HPLC verified · batch COA | No repackaged imports | No human-use claims |
|---|---|---|---|---|---|---|
GLP1-T Peptide
|
||||||
Other Peptide |
The "GLP1-T" Peptide
| Compare to: | ![]() GLP1-T Peptide |
Other Peptide |
|---|---|---|
| No fillers | ||
| No artificial additives | ||
| No excipients | ||
| 99%+ HPLC verified · batch COA | ||
| No repackaged imports | ||
| No human-use claims |
FAQs
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex) is a naturally occurring copper-binding tripeptide studied extensively in preclinical and in vitro research models. It is primarily researched for its role in tissue repair, collagen synthesis, wound healing, gene expression modulation, hair follicle biology, and antioxidant defense pathways.
Lyophilized means the compound has been freeze-dried — water is removed under vacuum to produce a stable powder. This process significantly extends shelf life and preserves compound integrity during storage and shipping. Lyophilized peptides are the research-grade standard because they maintain purity far longer than liquid formulations.
Each batch of GHK-Cu is independently verified at ≥99% purity using HPLC (High-Performance Liquid Chromatography). Identity is further confirmed by LC-MS (Liquid Chromatography-Mass Spectrometry). A batch-specific Certificate of Analysis (COA) is available for download before purchase.
Store lyophilized GHK-Cu at −20°C upon receipt. Keep protected from light, heat, and moisture. Do not open the vial until needed for your research protocol. Under proper storage conditions, lyophilized GHK-Cu maintains compound integrity for up to 24 months.
No. Peptides Verse does not provide reconstitution, dosing, or administration guidance of any kind. All reconstitution protocols are the sole responsibility of the qualified researcher or institution receiving this compound. This product is strictly for in vitro and laboratory research use only.
Yes. A batch-specific COA is available for every vial of GHK-Cu sold by Peptides Verse. The COA includes HPLC purity data, LC-MS identity confirmation, lot number, and testing lab details. It can be downloaded directly from the product page before or after purchase.
GHK refers to the free tripeptide (Glycyl-L-Histidyl-L-Lysine) without copper. GHK-Cu is the copper-chelated form — where a Cu² ion is bound to the tripeptide. The copper-chelated form is the biologically active version studied in most published research on wound healing, collagen synthesis, and gene expression modulation.
No. GHK-Cu from Peptides Verse is strictly for in vitro research and laboratory experimentation only. It is not intended for human or animal use of any kind. By purchasing, the buyer confirms they are a qualified researcher or institution and accepts full responsibility for safe handling and use.
All orders are shipped via FedEx with temperature-appropriate packaging to protect compound integrity during transit. Packaging is discreet — plain FedEx or UPS with no product branding on the exterior. Orders placed before 2 PM EST ship same business day.
Due to the nature of research chemicals, all sales are final once a vial has been opened or the seal broken. If you receive a damaged or incorrect item, contact support@peptidesverse.com within 48 hours of delivery with your order number and photos.